Welcome to our dedicated page for Royce Micro-Cap Trust news (Ticker: $RMT), a resource for investors and traders seeking the latest updates and insights on Royce Micro-Cap Trust stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Royce Micro-Cap Trust's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Royce Micro-Cap Trust's position in the market.
Royce Micro-Cap Trust (NYSE: RMT) as of Mar 31, 2024, reported an average weekly trading volume of approximately 538,245 shares. The fund's adviser boasts over 50 years of small- and micro-cap investment experience. The closing prices as of 03/31/24 indicated a NAV of 10.75 and MKT of 9.45. The average annual total return as of 03/31/24 showed positive growth across different timeframes, with the one-year return at 18.85% for NAV and 16.99% for MKT. The fund's portfolio diagnostics highlighted key metrics such as an average market cap of $769.4M, a weighted average P/B of 2.0x, and net assets totaling $539.4M.